Cite
MLA Citation
Mallika Lala et al.. “Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68–75].” European journal of cancer, vol. 144, 2021, pp. 400–. http://access.bl.uk/ark:/81055/vdc_100120049974.0x000023